- Breast cancer remains the most common cancer diagnosed and the second most common cause of cancer-related mortality among women in the United States (lung cancer is first):
- The American Cancer Society estimated that in 2016, approximately 246,660 new cases of invasive breast cancer will be diagnosed and nearly 40,450 breast cancer related deaths will occur.
- Estimated new cases and deaths from breast cancer (women only) in the United States in 2018:
- New cases:
- 268,670
- Deaths from breast cancer:
- 41,400
- New cases:
- Breast cancer is the most common non-cutaneous cancer in U.S. women:
- With an estimated 63,960 cases of in situ disease in 2018.
- 266,120 cases of invasive disease in 2018:
- Thus, fewer than one of six women diagnosed with breast cancer die of the disease:
- By comparison, it is estimated that about 70,500 American women will die of lung cancer in 2018.3. Men account for 1% of breast cancer cases and breast cancer deaths.
- Thus, fewer than one of six women diagnosed with breast cancer die of the disease:
- Currently, the lifetime risk of breast cancer among women is 1 in 8 or 12% compared to 1 in 11 for women in the 1970s:
- This increase in risk over the past four decades is attributed to:
- Longer life expectancy
- Changes in reproductive patterns
- Hormone use
- The rising prevalence of obesity
- As well as increased detection through screening mammography
- This increase in risk over the past four decades is attributed to:
- Although the incidence of breast cancer has risen:
- Breast cancer mortality has decreased:
- Breast cancer death rates have decreased 36% from 1989 to 2012, after slowly increasing (0.4% per year) since 1975:
- This likely reflects the increased use of screening mammography beginning in the early 1980s leading to detection of earlier stage disease, as well as continued improvements in systemic adjuvant therapy.
- Breast cancer death rates have decreased 36% from 1989 to 2012, after slowly increasing (0.4% per year) since 1975:
- Breast cancer mortality has decreased:
- Breast cancer incidence rates are highest in non-Hispanic white women, followed by African American women and are lowest among Asian/Pacific Islander women:
- Contrastingly, breast cancer death rates are highest for African American women, followed by non-Hispanic white women, and are lowest for Asian/Pacific Islander women:
- Furthermore, the difference in long-term breast cancer mortality by race/ethnicity persists and is increasing with breast cancer death rates 42% higher in African American than Caucasian women in 2012:
- This disparity reflects a combination of factors, including differences in stage at diagnosis, obesity, comorbidities, tumor characteristics, screening, access, adherence, and response to treatment.
- Furthermore, the difference in long-term breast cancer mortality by race/ethnicity persists and is increasing with breast cancer death rates 42% higher in African American than Caucasian women in 2012:
- Contrastingly, breast cancer death rates are highest for African American women, followed by non-Hispanic white women, and are lowest for Asian/Pacific Islander women:
Rodrigo Arrangoiz MS, MD, FACS a surgical oncologist and is a member of Sociedad Quirúrgica S.C at the America British Cowdray Medical Center in Mexico City:
-
He is an expert in the management of breast cancer.
- If you have any questions about breast cancer epidemiology please fill free to contact Dr. Arrangoiz.
Training:
• General surgery:
• Michigan State University:
• 2004 al 2010
• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:
• Fox Chase Cancer Center (Filadelfia):
• 2010 al 2012
• Masters in Science (Clinical research for health professionals):
• Drexel University (Filadelfia):
• 2010 al 2012
• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:
• IFHNOS / Memorial Sloan Kettering Cancer Center:
• 2014 al 2016
#Arrangoiz
#Surgeon
#Cirujano
#SurgicalOncologist
#CirujanoOncologo
#BreastSurgeon
#CirujanodeMama
#CancerSurgeon
#CirujanodeCancer
http://www.sociedadquirurigca.com










